{"filing":{"accession_number":"0001437749-26-020793","cik":"0001401667","ticker":"PBYI","company_name":"PUMA BIOTECHNOLOGY, INC.","form":"8-K","filing_date":"2026-06-16","report_date":null,"primary_document":"pbyi20260613_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020793/pbyi20260613_8k.htm"},"events":[{"id":11301,"run_id":9919,"accession_number":"0001437749-26-020793","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 11, 2026, filed under Item 5.07. The filing reports voting outcomes on four proposals: election of eight directors, ratification of KPMG LLP as auditor, advisory approval of named executive officer compensation, and a failed warrant amendment for CEO Alan H. Auerbach. The material outcome is the rejection of Proposal 4 (warrant extension), where votes against (19,596,238) exceeded votes for (18,234,150).","company_name":"PUMA BIOTECHNOLOGY, INC.","ticker":"PBYI","filing_date":"2026-06-16","form":"8-K","submitted_at":null,"items":[{"id":7858,"accession_number":"0001437749-26-020793","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 11, 2026, filed under Item 5.07. The filing reports voting outcomes on four proposals: election of eight directors, ratification of KPMG LLP as auditor, advisory approval of named executive officer compensation, and a failed warrant amendment for CEO Alan H. Auerbach. The material outcome is the rejection of Proposal 4 (warrant extension), where votes against (19,596,238) exceeded votes for (18,234,150).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T20:09:00.336110+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7858,"accession_number":"0001437749-26-020793","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 11, 2026, filed under Item 5.07. The filing reports voting outcomes on four proposals: election of eight directors, ratification of KPMG LLP as auditor, advisory approval of named executive officer compensation, and a failed warrant amendment for CEO Alan H. Auerbach. The material outcome is the rejection of Proposal 4 (warrant extension), where votes against (19,596,238) exceeded votes for (18,234,150).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T20:09:00.336110+00:00","company_name":"PUMA BIOTECHNOLOGY, INC.","ticker":"PBYI","filing_date":"2026-06-16"}]}